These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. The role of natriuretic peptides in cardioprotection. Nishikimi T; Maeda N; Matsuoka H Cardiovasc Res; 2006 Feb; 69(2):318-28. PubMed ID: 16289003 [TBL] [Abstract][Full Text] [Related]
45. Natriuretic peptide system in the human retina. Rollín R; Mediero A; Roldán-Pallarés M; Fernández-Cruz A; Fernández-Durango R Mol Vis; 2004 Jan; 10():15-22. PubMed ID: 14737067 [TBL] [Abstract][Full Text] [Related]
46. Natriuretic peptides in heart valve disease. Ray SG Heart; 2006 Sep; 92(9):1194-7. PubMed ID: 16251227 [TBL] [Abstract][Full Text] [Related]
47. Natriuretic peptide family: new aspects. Cea LB Curr Med Chem Cardiovasc Hematol Agents; 2005 Apr; 3(2):87-98. PubMed ID: 15853696 [TBL] [Abstract][Full Text] [Related]
48. Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure. Tsukamoto O; Fujita M; Kato M; Yamazaki S; Asano Y; Ogai A; Okazaki H; Asai M; Nagamachi Y; Maeda N; Shintani Y; Minamino T; Asakura M; Kishimoto I; Funahashi T; Tomoike H; Kitakaze M J Am Coll Cardiol; 2009 Jun; 53(22):2070-7. PubMed ID: 19477358 [TBL] [Abstract][Full Text] [Related]
49. Effect of exercise on natriuretic peptides in plasma and urine in chronic heart failure. Bentzen H; Pedersen RS; Nyvad O; Pedersen EB Int J Cardiol; 2004 Feb; 93(2-3):121-30. PubMed ID: 14975537 [TBL] [Abstract][Full Text] [Related]
50. [Natriuretic peptides--is it time for clinical use?]. Nir A; Rein AJ; Hassin Y Harefuah; 1999 Mar; 136(5):386-90. PubMed ID: 10914246 [No Abstract] [Full Text] [Related]
51. [Type B natriuretic peptide. Role in heart failure physiopathology, diagnosis, and prognosis]. Bettencourt P; Azevedo A Rev Port Cardiol; 2004 May; 23 Suppl 2():II95-104. PubMed ID: 15222253 [TBL] [Abstract][Full Text] [Related]
54. Natriuretic peptides and the management of heart failure. Calderone A Minerva Endocrinol; 2004 Sep; 29(3):113-27. PubMed ID: 15282444 [TBL] [Abstract][Full Text] [Related]
55. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure. von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563 [TBL] [Abstract][Full Text] [Related]
56. Water and sodium regulation in chronic heart failure: the role of natriuretic peptides and vasopressin. Kalra PR; Anker SD; Coats AJ Cardiovasc Res; 2001 Aug; 51(3):495-509. PubMed ID: 11476740 [No Abstract] [Full Text] [Related]
57. Regional sampling and the effects of experimental heart failure in sheep: differential responses in A, B and C-type natriuretic peptides. Charles CJ; Prickett TC; Espiner EA; Rademaker MT; Richards AM; Yandle TG Peptides; 2006 Jan; 27(1):62-8. PubMed ID: 16095755 [TBL] [Abstract][Full Text] [Related]
58. Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure. Kuhn M; Voss M; Mitko D; Stypmann J; Schmid C; Kawaguchi N; Grabellus F; Baba HA Cardiovasc Res; 2004 Nov; 64(2):308-14. PubMed ID: 15485690 [TBL] [Abstract][Full Text] [Related]
59. Structural determinants of natriuretic peptide receptor specificity and degeneracy. He XL; Dukkipati A; Garcia KC J Mol Biol; 2006 Aug; 361(4):698-714. PubMed ID: 16870210 [TBL] [Abstract][Full Text] [Related]
60. [Atrial and B-type natriuretic peptides: from the research lab to clinical practice]. Boomsma F; van den Meiracker AH Ned Tijdschr Geneeskd; 2003 Apr; 147(16):743-8. PubMed ID: 12731463 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]